Active, Not RecruitingPhase 2ketamine

Understanding How Ketamine Brings About Rapid Improvement in OCD

Sponsored by Stanford University

NCT ID
NCT02624596
Target Enrollment
120 participants
Start Date
2016-06
Est. Completion
2026-06

About This Study

The purpose of this study is to understand how ketamine brings about rapid improvement in Obsessive-Compulsive Disorder (OCD) symptoms.

Conditions Studied

Obsessive-Compulsive Disorder

Interventions

  • Ketamine
  • Midazolam

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria for participants with OCD:

* age 18-65
* Primary diagnosis of OCD
* Sufficient severity of OCD symptoms
* ability to tolerate a treatment-free period
* capacity to provide informed consent

Inclusion criteria for healthy controls:

* ages 18-65
* capacity to provide informed consent

Exclusion criteria for participants with OCD:

* Psychiatric or medical conditions that make participation unsafe
* pregnant or nursing females
* concurrent use of any medications that might increase the risk of participation (e.g. drug interactions)
* presence of metallic device or dental braces

Exclusion criteria for healthy controls:

* any current or lifetime psychiatric diagnosis
* pregnant or nursing females
* major medical or neurological problem
* presence of metallic device or dental braces

Study Locations (1)

Stanford University
Stanford, California, United States

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Understanding How Ketamine Brings About Rapid Improvement in OCD | Huxley